239 related articles for article (PubMed ID: 20926450)
1. Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53.
He X; Ni Y; Wang Y; Romigh T; Eng C
Hum Mol Genet; 2011 Jan; 20(1):80-9. PubMed ID: 20926450
[TBL] [Abstract][Full Text] [Related]
2. Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function.
Lobo GP; Waite KA; Planchon SM; Romigh T; Nassif NT; Eng C
Hum Mol Genet; 2009 Aug; 18(15):2851-62. PubMed ID: 19457929
[TBL] [Abstract][Full Text] [Related]
3. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.
Bennett KL; Mester J; Eng C
JAMA; 2010 Dec; 304(24):2724-31. PubMed ID: 21177507
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer.
Agrawal S; Eng C
Hum Mol Genet; 2006 Mar; 15(5):777-87. PubMed ID: 16436456
[TBL] [Abstract][Full Text] [Related]
5. PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner.
Tang Y; Eng C
Cancer Res; 2006 Jan; 66(2):736-42. PubMed ID: 16424003
[TBL] [Abstract][Full Text] [Related]
6. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
[TBL] [Abstract][Full Text] [Related]
7. Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through SRC-induced PTEN oxidation.
Yu W; He X; Ni Y; Ngeow J; Eng C
Hum Mol Genet; 2015 Jan; 24(1):142-53. PubMed ID: 25149476
[TBL] [Abstract][Full Text] [Related]
8. PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression.
Chang CJ; Mulholland DJ; Valamehr B; Mosessian S; Sellers WR; Wu H
Mol Cell Biol; 2008 May; 28(10):3281-9. PubMed ID: 18332125
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor PTEN interacts with p53 in hereditary cancer (Review).
Nakanishi A; Kitagishi Y; Ogura Y; Matsuda S
Int J Oncol; 2014 Jun; 44(6):1813-9. PubMed ID: 24718924
[TBL] [Abstract][Full Text] [Related]
10. Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation.
Teresi RE; Zbuk KM; Pezzolesi MG; Waite KA; Eng C
Am J Hum Genet; 2007 Oct; 81(4):756-67. PubMed ID: 17847000
[TBL] [Abstract][Full Text] [Related]
11. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53.
Ni Y; He X; Chen J; Moline J; Mester J; Orloff MS; Ringel MD; Eng C
Hum Mol Genet; 2012 Jan; 21(2):300-10. PubMed ID: 21979946
[TBL] [Abstract][Full Text] [Related]
12. ATP modulates PTEN subcellular localization in multiple cancer cell lines.
Lobo GP; Waite KA; Planchon SM; Romigh T; Houghton JA; Eng C
Hum Mol Genet; 2008 Sep; 17(18):2877-85. PubMed ID: 18579579
[TBL] [Abstract][Full Text] [Related]
13. Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes.
Smith IN; Thacker S; Jaini R; Eng C
J Biomol Struct Dyn; 2019 Apr; 37(7):1766-1782. PubMed ID: 29663862
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Cowden syndrome patient with a novel PTEN mutation and establishment of patient-derived induced pluripotent stem cells.
Obayashi F; Hamada A; Yamasaki S; Kanda T; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):69-78. PubMed ID: 34984555
[TBL] [Abstract][Full Text] [Related]
15. PTEN phosphorylation and nuclear export mediate free fatty acid-induced oxidative stress.
Wu Y; Zhou H; Wu K; Lee S; Li R; Liu X
Antioxid Redox Signal; 2014 Mar; 20(9):1382-95. PubMed ID: 24063548
[TBL] [Abstract][Full Text] [Related]
16. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes.
Pezzolesi MG; Li Y; Zhou XP; Pilarski R; Shen L; Eng C
Am J Hum Genet; 2006 Nov; 79(5):923-34. PubMed ID: 17033968
[TBL] [Abstract][Full Text] [Related]
17. Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cells.
Yu W; Ni Y; Saji M; Ringel MD; Jaini R; Eng C
Hum Mol Genet; 2017 Apr; 26(7):1365-1375. PubMed ID: 28164237
[TBL] [Abstract][Full Text] [Related]
18. p53 down-regulates phosphatase and tensin homologue deleted on chromosome 10 protein stability partially through caspase-mediated degradation in cells with proteasome dysfunction.
Tang Y; Eng C
Cancer Res; 2006 Jun; 66(12):6139-48. PubMed ID: 16778187
[TBL] [Abstract][Full Text] [Related]
19. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
20. PTEN expression in U251 glioma cells enhances their sensitivity to ionizing radiation by suppressing DNA repair capacity.
Li HL; Wang CY; Fu J; Yang XJ; Sun Y; Shao YH; Zhang LH; Yang XM; Zhang XL; Lin J
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10453-10458. PubMed ID: 31841199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
